ElementZero BioLabs
Bringing diagnostics tests, 100x more sensitive, to point of care
The new trends in medicine have one thing in common: the quest for a full understanding of genetics. The 24B EUR market of tools for genetic analysis still lacks solutions for exploring difficult genetic targets.
ElementZero BioLabs’ special reagents provide access to novel genetic targets while reducing the analysis time of biological samples by 100x, with 1000x higher efficiency than any other solution in the market.
We have been working with two leading research labs and are currently developing use cases for our technology to tackle Covid-19 crisis.
Founders
John Moura
CEO, ElementZero Biolabs
Led product development, sales, and operations in global companies
Karol Rogowski
CTO, ElementZero Biolabs
PhD in Biochemistry, experienced in RNA/DNA research